Bristol-Myers Squibb traded at $72.65 this Tuesday January 31st, increasing $0.62 or 0.86 percent since the previous trading session. Looking back, over the last four weeks, Bristol-Myers Squibb gained 0.54 percent. Over the last 12 months, its price rose by 11.44 percent. Looking ahead, we forecast Bristol-Myers Squibb to be priced at 70.06 by the end of this quarter and at 63.39 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
72.65
Daily Change
0.86%
Yearly
11.44%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 147.75 2.10 1.44% 7.85%
Abbott 110.55 0.74 0.67% -14.99%
ALKERMES 28.64 -0.15 -0.52% 13.34%
Amgen 252.40 0.81 0.32% 10.37%
AstraZeneca 10,592.00 -118.00 -1.10% 24.48%
AstraZeneca 65.37 -0.47 -0.71% 13.33%
Biogen 290.90 4.96 1.73% 26.83%
Bristol-Myers Squibb 72.65 0.62 0.86% 11.44%
Coherus Biosciences 8.48 0.34 4.18% -32.86%
Catalent 53.55 0.97 1.84% -49.75%
Endo International 0.09 -0.0001 -0.11% -97.04%
Gilead Sciences 83.94 0.59 0.71% 22.59%
GlaxoSmithKline 1,427.60 14.60 1.03% -13.17%
Horizon Pharma 109.72 -0.33 -0.30% 16.32%
Intercept Pharmaceuticals 18.26 0.32 1.78% 7.98%
Jazz Pharmaceuticals 156.66 2.89 1.88% 11.27%
J&J 163.42 1.42 0.88% -4.37%
Lannett 0.55 0.01 2.56% -64.55%
Eli Lilly 344.12 3.65 1.07% 38.60%
Medtronic 83.69 1.11 1.34% -19.04%
Merck & Co 107.41 1.32 1.24% 31.12%
Novartis 82.65 -0.52 -0.63% 1.91%
Phibro Animal Health 15.40 0.30 1.99% -19.96%
Prestige Brands 65.76 0.27 0.41% 16.14%
Pfizer 44.16 0.61 1.40% -16.79%
Perrigo 37.42 0.04 0.11% -1.84%
Drreddys Laboratories 53.80 0.28 0.52% -5.91%
Regeneron Pharmaceuticals 758.01 22.01 2.99% 23.58%
Roche Holding 285.40 -2.80 -0.97% -20.62%
Revance Therapeutics 34.68 1.86 5.67% 156.51%
Sanofi 89.92 0.13 0.14% -1.82%
Sanofi 49.14 0.57 1.17% -4.82%
Teva Pharmaceutical Industries 10.54 0.28 2.73% 21.01%
United Therapeutics 263.17 4.46 1.72% 29.66%
Zoetis 165.49 0.79 0.48% -16.78%

Indexes Price Day Year
US500 4066 58.83 1.46% -11.41%

Bristol-Myers Squibb
Bristol-Myers Squibb Company is a biopharmaceutical company. The Company is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. It offers products for a range of therapeutic classes, which include oncology, immunology, cardiovascular and fibrosis. Its pharmaceutical products include chemically-synthesized or small molecule drugs and products produced from biological processes, called biologics. Small molecule drugs are administered orally in the form of a pill or tablet. Biologics are administered to patients through injections or by infusion. Its products include Revlimid, Eliquis, Opdivo, Orencia, Pomalyst/Imnovid, Sprycel, Yervoy, Abraxane, Empliciti, Reblozyl, Inrebic, Onureg, Zeposia, Vidaza, Baraclude and Breyanzi. Its products are sold to wholesalers, distributors, pharmacies, retailers, hospitals, clinics and government agencies.